Kenneth Lee is Head of Commercial Division of Americas from GenScript ProBio. As a Senior Manager of Commercial Strategy at Samsung Bioepis, Kenneth led global commercialization of high-quality pipeline of biosimilars, most notably in the US, EU, Canada, and Australia. Kenneth headed international business development at Binex Co. Ltd., a well-established CDMO in South Korea, and has an MBA degree from INSEAD.

 In his current position within Pall Corporation, Peter Levison is responsible for developing strategic partnerships and collaborations within the Biotech community through the management of a network of Global Thought Leaders and collaborative partners. Working with key industrialists and academics around the world, Peter is actively looking for solutions to tomorrow’s challenges today. Previously he has held global product management leadership roles in batch and continuous downstream processing. He joined Pall in July 2003 and has many years’ experience in the biopharmaceutical industry, holding positions of increasing responsibility in research and development, technical management, product management and business development. 
 
Dr. Levison holds a BSc (Hons) Class I in Biochemistry from the University of Manchester, Manchester, UK and a PhD gained in the Dept. of Biochemistry, University of Manchester. He has an MBA awarded through the Open University Business School, Milton Keynes, UK. He is a member of various professional bodies and has the status of C.Chem, FRSC (Chartered Chemist and Fellow of the Royal Society of Chemistry in the UK) and C.Biol, FRSB (Chartered Biologist and Fellow of the Royal Society of Biology in the UK)

Ratish Krishnan is an Associate Director for Cell & Gene Therapy BioProcessing for the Americas at MilliporeSigma. He is a Process Development Scientist by background and has a decade of experience in vaccine, monoclonal antibodies and viral vector modalities from pre-clinical to late stage process characterization, validation and commercialization activities such as BLA authoring. He is passionate about providing solutions to bring treatments to market. As a BioChemical engineer from South India, he holds a Master’s degree in Biotechnology from the Pennsylvania State University. Ratish has managed process development teams at leading companies such as Novartis and Pfizer prior to his current role in 2019 where he serves as a technical consultant and initiates strategic collaborations and partnerships in gene therapy. He has presented scientific lectures at conferences, webinars and has made key contributions in peer-reviewed journals, articles and white papers